financetom
Business
financetom
/
Business
/
Pharma firm Granules India hit by IT security breach; stock tanks 2%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pharma firm Granules India hit by IT security breach; stock tanks 2%
May 25, 2023 3:43 AM

Hyderabad-based pharmaceutical company Granules India on Thursday informed the stock exchanges about an information technology security breach. The stock of Granules India tumbled 2 percent in Thursday's trade. At 12:33 pm, the script was trading 1.94 percent lower at Rs 273.50 apiece on the BSE.

Share Market Live

NSE

The company said that it was investigating the matter and actions were being taken to address the incident.

ALSO READ: HDFC Bank shares at Rs 1,960? Analysts see up to 21% upside post-management meet

"Please be informed that an information security incident has occurred at the company and the impacted IT assets have been isolated. The company is investigating the matter with utmost priority. The appropriate containment and remediation actions are being taken in a controlled manner to address the incident," the firm said in a regulatory filing.

This is the second pharma company to see a similar incident within a year. Back in March, drug major Sun Pharma reported an "information security incident" at the company. As many as 25 days later, a ransomware group claimed responsibility for the information breach.

As a result, Sun Pharma's business operations were impacted, due to which, the revenue in some businesses will be lower. The company added that it is currently unable to determine other "potential adverse impacts" of the incident, including other security incidents or the possibility of litigation.

Expenses in connection with the incident and the subsequent remediation will also be borne by the company.

ALSO READ: Day trading guide: Tata Power to Suzlon — stocks to buy or sell today

Granules Q4 earnings

Granules India’s net profit increased by 8 percent to Rs 120 crore in the fourth quarter that ended March 31, 2023, compared with Rs 111 crore in the same period last year, the company said in a filing recently.

Revenue of the Hyderabad-based company surged 16 percent to Rs 1,195 crore as compared to Rs 1,030 crore in the year-ago period. The revenue growth was primarily driven by higher sales in key geographies including the US and Europe. Revenue share from the US increased to 54 percent in the quarter under review as against 48 percent in the same period last year.

First Published:May 25, 2023 12:43 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Wedbush Raises Willdan Group's PT to $30 From $25 After 'Blowout' Q4 2023 Results, Notes 'Conservative' 2024 Guidance; Maintains Outperform Rating
--Wedbush Raises Willdan Group's PT to $30 From $25 After 'Blowout' Q4 2023 Results, Notes 'Conservative' 2024 Guidance; Maintains Outperform Rating
Mar 8, 2024
06:31 AM EST, 03/08/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) Price: 23, Change: +3.15, Percent Change: +15.87 ...
Update: Costco Fiscal Q2 Earnings Increase But Sales Growth Misses Forecast; Shares Drop Premarket
Update: Costco Fiscal Q2 Earnings Increase But Sales Growth Misses Forecast; Shares Drop Premarket
Mar 8, 2024
06:39 AM EST, 03/08/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Costco Wholesale ( COST ) shares dropped 4.6% in premarket activity Friday after the company's fiscal Q2 results showed the increase in net sales lagged market expectations. The company reported fiscal Q2 earnings late Thursday of $3.92 per diluted share, up...
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China
Mar 8, 2024
06:28 AM EST, 03/08/2024 (MT Newswires) -- Cytek Biosciences ( CTKB ) on late Thursday unveiled a new manufacturing facility for cell analysis systems in Wuxi, China. The 50,000-square-foot facility will also support the operations, research and development, marketing, human resources and sales teams of Cytek Wuxi, the company said. Price: 7.51, Change: +0.36, Percent Change: +4.96 ...
Natera Insider Sold Shares Worth $16,694,485, According to a Recent SEC Filing
Natera Insider Sold Shares Worth $16,694,485, According to a Recent SEC Filing
Mar 8, 2024
06:37 AM EST, 03/08/2024 (MT Newswires) -- Matthew Rabinowitz, Director, EXECUTIVE CHAIRMAN, on March 05, 2024, sold 191,012 shares in Natera ( NTRA ) for $16,694,485. Following the Form 4 filing with the SEC, Rabinowitz has control over a total of 1,935,684 shares of the company, with 1,075,648 shares held directly and 860,036 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1604821/000141588924007241/xslF345X03/form4-03072024_090301.xml Price:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved